Transmission of COVID-19 and other infectious diseases in public washrooms: A systematic review.

Aerosol Bacterial and viral contamination Environmental exposure Hand drying Public toilet SARS-CoV-2

Journal

The Science of the total environment
ISSN: 1879-1026
Titre abrégé: Sci Total Environ
Pays: Netherlands
ID NLM: 0330500

Informations de publication

Date de publication:
10 Jan 2022
Historique:
received: 12 07 2021
revised: 13 08 2021
accepted: 23 08 2021
pubmed: 17 9 2021
medline: 18 11 2021
entrez: 16 9 2021
Statut: ppublish

Résumé

The risk of infectious disease transmission in public washrooms causes concern particularly in the context of the COVID-19 pandemic. This systematic review aims to assess the risk of transmission of viral or bacterial infections through inhalation, surface contact, and faecal-oral routes in public washrooms in healthcare and non-healthcare environments. We systematically reviewed environmental sampling, laboratory, and epidemiological studies on viral and bacterial infection transmission in washrooms using PubMed and Scopus. The review focused on indoor, publicly accessible washrooms. Thirty-eight studies from 13 countries were identified, including 14 studies carried out in healthcare settings, 10 in laboratories or experimental chambers, and 14 studies in restaurants, workplaces, commercial and academic environments. Thirty-three studies involved surface sampling, 15 air sampling, 8 water sampling, and 5 studies were risk assessments or outbreak investigations. Infectious disease transmission was studied in relation with: (a) toilets with flushing mechanisms; (b) hand drying systems; and (c) water taps, sinks and drains. A wide range of enteric, skin and soil bacteria and enteric and respiratory viruses were identified in public washrooms, potentially posing a risk of infection transmission. Studies on COVID-19 transmission only examined washroom contamination in healthcare settings. Open-lid toilet flushing, ineffective handwashing or hand drying, substandard or infrequent surface cleaning, blocked drains, and uncovered rubbish bins can result in widespread bacterial and/or viral contamination in washrooms. However, only a few cases of infectious diseases mostly related to faecal-oral transmission originating from washrooms in restaurants were reported. Although there is a risk of microbial aerosolisation from toilet flushing and the use of hand drying systems, we found no evidence of airborne transmission of enteric or respiratory pathogens, including COVID-19, in public washrooms. Appropriate hand hygiene, surface cleaning and disinfection, and washroom maintenance and ventilation are likely to minimise the risk of infectious disease transmission.

Sections du résumé

BACKGROUND BACKGROUND
The risk of infectious disease transmission in public washrooms causes concern particularly in the context of the COVID-19 pandemic. This systematic review aims to assess the risk of transmission of viral or bacterial infections through inhalation, surface contact, and faecal-oral routes in public washrooms in healthcare and non-healthcare environments.
METHODS METHODS
We systematically reviewed environmental sampling, laboratory, and epidemiological studies on viral and bacterial infection transmission in washrooms using PubMed and Scopus. The review focused on indoor, publicly accessible washrooms.
RESULTS RESULTS
Thirty-eight studies from 13 countries were identified, including 14 studies carried out in healthcare settings, 10 in laboratories or experimental chambers, and 14 studies in restaurants, workplaces, commercial and academic environments. Thirty-three studies involved surface sampling, 15 air sampling, 8 water sampling, and 5 studies were risk assessments or outbreak investigations. Infectious disease transmission was studied in relation with: (a) toilets with flushing mechanisms; (b) hand drying systems; and (c) water taps, sinks and drains. A wide range of enteric, skin and soil bacteria and enteric and respiratory viruses were identified in public washrooms, potentially posing a risk of infection transmission. Studies on COVID-19 transmission only examined washroom contamination in healthcare settings.
CONCLUSION CONCLUSIONS
Open-lid toilet flushing, ineffective handwashing or hand drying, substandard or infrequent surface cleaning, blocked drains, and uncovered rubbish bins can result in widespread bacterial and/or viral contamination in washrooms. However, only a few cases of infectious diseases mostly related to faecal-oral transmission originating from washrooms in restaurants were reported. Although there is a risk of microbial aerosolisation from toilet flushing and the use of hand drying systems, we found no evidence of airborne transmission of enteric or respiratory pathogens, including COVID-19, in public washrooms. Appropriate hand hygiene, surface cleaning and disinfection, and washroom maintenance and ventilation are likely to minimise the risk of infectious disease transmission.

Identifiants

pubmed: 34525681
pii: S0048-9697(21)05007-5
doi: 10.1016/j.scitotenv.2021.149932
pmc: PMC8390098
pii:
doi:

Types de publication

Journal Article Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

149932

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: SV is member of the Dyson Scientific Advisory Board and has received research funding and honoraria from Dyson.

Références

Sci Total Environ. 2021 Oct 20;792:148341
pubmed: 34146809
Phys Fluids (1994). 2020 Aug 1;32(8):081703
pubmed: 32831536
Aust N Z J Public Health. 2020 Oct;44(5):333-335
pubmed: 32833313
J Hosp Infect. 2018 Dec;100(4):469-475
pubmed: 30006281
J Water Health. 2019 Dec;17(6):863-869
pubmed: 31850894
BMJ. 2009 Jul 21;339:b2535
pubmed: 19622551
Sci Total Environ. 2021 Jan 20;753:141710
pubmed: 32891988
PLoS Pathog. 2017 Aug 10;13(8):e1006369
pubmed: 28796836
Environ Int. 2020 Sep;142:105832
pubmed: 32521345
PLoS One. 2017 Feb 10;12(2):e0171556
pubmed: 28187135
Am J Infect Control. 2018 May;46(5):507-511
pubmed: 29305284
Phys Fluids (1994). 2020 Jun 1;32(6):065107
pubmed: 32574232
J Infect Dis. 2013 Jul 15;208(2):295-8
pubmed: 23559462
Int J Environ Res Public Health. 2016 Jul 20;13(7):
pubmed: 27447658
J Appl Microbiol. 2012 Mar;112(3):614-21
pubmed: 22229855
Indoor Air. 2018 Jul;28(4):500-524
pubmed: 29683213
J Hosp Infect. 2014 Dec;88(4):199-206
pubmed: 25237036
Appl Environ Microbiol. 2018 Apr 2;84(8):
pubmed: 29439992
J Hosp Infect. 2001 Oct;49(2):117-21
pubmed: 11567556
Eur Rev Med Pharmacol Sci. 2020 Sep;24(17):9202-9207
pubmed: 32965015
J Hosp Infect. 2017 Nov;97(3):296-300
pubmed: 28756169
J Hosp Infect. 2012 Sep;82(1):19-24
pubmed: 22841682
Appl Environ Microbiol. 2011 May;77(9):2898-904
pubmed: 21421792
Mayo Clin Proc. 2012 Aug;87(8):791-8
pubmed: 22656243
J Food Prot. 2009 Aug;72(8):1753-5
pubmed: 19722414
J Hosp Infect. 2021 Feb;108:189-196
pubmed: 33259882
Lett Appl Microbiol. 2017 Jan;64(1):19-26
pubmed: 27718259
J Infect Prev. 2019 Mar;20(2):66-74
pubmed: 30944590
PLoS Negl Trop Dis. 2020 Oct 9;14(10):e0008570
pubmed: 33035211
J Appl Microbiol. 2000 Dec;89(6):910-9
pubmed: 11123464
Nature. 2020 Jun;582(7813):557-560
pubmed: 32340022
J Appl Microbiol. 2011 Jan;110(1):19-26
pubmed: 20887403
Am J Infect Control. 2014 Jul;42(7):758-62
pubmed: 24818773
J UOEH. 2014 Jun 1;36(2):135-9
pubmed: 24930878
PLoS One. 2011;6(11):e28132
pubmed: 22132229
J Food Prot. 2009 Jan;72(1):111-9
pubmed: 19205471
Appl Environ Microbiol. 2015 Jul;81(13):4498-506
pubmed: 25911488
Indoor Air. 2021 Sep;31(5):1427-1440
pubmed: 33569864
Indoor Air. 2006 Oct;16(5):335-47
pubmed: 16948710
Sci Total Environ. 2021 Jan 20;753:141758
pubmed: 32898806
Antimicrob Resist Infect Control. 2018 Jan 26;7:16
pubmed: 29423191
J Hosp Infect. 2012 Jan;80(1):1-5
pubmed: 22137761
Am J Infect Control. 2003 Nov;31(7):387-91
pubmed: 14639433
J Hosp Infect. 2020 Jul;105(3):397-398
pubmed: 32315667
Emerg Infect Dis. 2020 Aug;26(8):1920-1922
pubmed: 32421494
Epidemiol Infect. 1997 Dec;119(3):319-25
pubmed: 9440435
J Hosp Infect. 2015 Mar;89(3):215-7
pubmed: 25586988
Int J Hyg Environ Health. 2019 Apr;222(3):479-485
pubmed: 30655228
Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16393-9
pubmed: 19805310
Saudi J Biol Sci. 2016 Mar;23(2):268-71
pubmed: 26981009
Am J Infect Control. 2019 May;47(5):515-520
pubmed: 30554881
Am J Infect Control. 2020 Dec;48(12):1540-1542
pubmed: 32763347
Gastroenterology. 2020 May;158(6):1518-1519
pubmed: 32142785
China CDC Wkly. 2020 Feb 21;2(8):123-124
pubmed: 34594837
Antimicrob Resist Infect Control. 2019 Feb 28;8:47
pubmed: 30867901
Psychol Rep. 2009 Dec;105(3 Pt 1):789-90
pubmed: 20099540
PLoS One. 2013;8(1):e54223
pubmed: 23349833
JAMA. 2020 Apr 28;323(16):1610-1612
pubmed: 32129805
J Appl Microbiol. 2013 Aug;115(2):572-82
pubmed: 23683001
J Appl Microbiol. 2016 Feb;120(2):478-86
pubmed: 26618932
Ann Intern Med. 2020 Dec 15;173(12):974-980
pubmed: 32870707
J Infect. 2005 Aug;51(2):103-9
pubmed: 16038759
Phys Fluids (1994). 2021 Mar;33(3):033320
pubmed: 33897239
Antimicrob Resist Infect Control. 2020 Oct 29;9(1):167
pubmed: 33121538
Am J Infect Control. 2016 Dec 1;44(12):1692-1694
pubmed: 27575773

Auteurs

Sotiris Vardoulakis (S)

National Centre for Epidemiology and Population Health, Research School of Population Health, Australian National University, Canberra, ACT 2601, Australia. Electronic address: sotiris.vardoulakis@anu.edu.au.

Daniela A Espinoza Oyarce (DA)

National Centre for Epidemiology and Population Health, Research School of Population Health, Australian National University, Canberra, ACT 2601, Australia.

Erica Donner (E)

Future Industries Institute, University of South Australia, Mawson Lakes, SA 5095, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH